Visionsense Corp Announces 500 Patients Milestone With Neurosurgical 3D Camera at Emory University Hospital in Atlanta, GA
Sep 28, 2011, 11:39 ET
NEW YORK, Sept. 28, 2011 /PRNewswire/ -- Visionsense Corp announces an unique milestone this week when the 3D camera was used in its 500th neurosurgical procedure with the VSii system.
Dr. Nelson M. Oyesiku (Al Lerner Chair and Vice-Chairman, Dept of Neurosurgery at Emory University and Professor of Neurosurgery and Medicine (Endocrinology)) performed a transsphenoidal resection of a pituitary adenoma in the morning of September 22nd, 2011 triggering this milestone accomplishment in the use of the 3D camera in transsphenoidal surgery.
Dr. Oyesiku commented, "The Visionsense system takes the best features of a 2D endoscope and a 3D surgical microscope and melds them into one instrument. The reason why 3 dimensional vision (stereopsis) is very important is, it provides an accurate rendition of the surgical field without image distortion, which is critical when operating around and within critical structures in the brain."
Alex Chanin, the CEO of Visionsense, stated that "Visionsense celebrated this important milestone on the road of 3D soon becoming the standard of care in visualization in the operating room."
About Visionsense Corp.
Founded 13 years ago, located in (New York, NY) with R&D subsidiary (Visionsense Ltd.) based in Israel. Visionsense develops miniature, three-dimensional (3-D) stereoscopic visualizations solutions for minimally invasive surgery. The company's digital platform technology is based on a customized, miniature 3-D (3.3 millimeter microchip) camera combined with image processing software that digitally maps anatomical structures in the surgical field, allowing surgeons to see in three dimensions.
CONTACT: Alex Chanin, +1-732-895-7710
SOURCE Visionsense Corp
Share this article